Loading stock data…
$1.23-0.04 (-3.54%)
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
PetMed Express, Inc. in the Healthcare sector is trading at $1.23 with a market capitalization of $37M. Wall Street consensus targets $1.40 (1 analysts), implying a +14.3% move over the next 12 months. The stock is currently near its 52-week low of $1.22, remaining 45.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 5 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $41.02M↓ | $42.82M↑ | $40.66M↓ | $44.36M↓ | $51.18M |
| Gross Profit | $11.33M↓ | $13.94M↑ | $9.46M↓ | $12.41M↓ | $14.40M |
| Operating Income | -$6.23M↓ | -$5.69M↑ | -$10.47M↓ | -$8.38M↓ | -$6.87M |
| Net Income | -$6.14M↓ | -$4.06M↑ | -$10.55M↓ | -$8.52M↑ | -$34.15M |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers no...